Beneficial effects of interferon‐α2b in Behçet's disease
Open Access
- 1 July 1993
- journal article
- case report
- Published by Wiley in Arthritis & Rheumatism
- Vol. 36 (7) , 1025-1026
- https://doi.org/10.1002/art.1780360721
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Interferons — Expanding Therapeutic RolesNew England Journal of Medicine, 1992
- Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of InfancyNew England Journal of Medicine, 1992
- Interferon Alpha 2a For Treatment of Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 1991
- Behçet's SyndromeNew England Journal of Medicine, 1990
- TREATMENT OF HAEMANGIOENDOTHELIOMAS WITH ALPHA INTERFERONThe Lancet, 1989
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- IMPAIRED PROSTACYCLIN SYNTHESIS BY VESSEL WALLS IN BEHÇET'S DISEASEThe Lancet, 1986
- Inhibition of Cell Motility by InterferonScience, 1980
- Behcet's syndrome and autoimmunity.BMJ, 1967
- Further Investigations on the Virus of Behcet's Disease* *From the Ziya Gun Institute for Research in Trachoma, University of Istanbul. Supported by a grant‐in‐aid awarded by the National Council to Combat Blindness, Inc.American Journal of Ophthalmology, 1956